Technology News and Research

RSS

Scientists discover novel virus that may shed light on viral evolution

Scientists discover novel virus that may shed light on viral evolution

Viruses are non-living creatures, consisting of genetic material encased in a protein coat. Once the virus infects a living organism, it can replicate itself and continue on. But what happens if a virus lacks the proper tools to infect an organism? How can it propagate?

16 Oct 2019

Nanomeshes could be effective drug delivery system for antibiotics

Nanomeshes could be effective drug delivery system for antibiotics

The fight against global antibiotic resistance has taken a major step forward with scientists discovering a concept for fabricating nanomeshes as an effective drug delivery system for antibiotics.

16 Oct 2019

Researchers develop new smart speaker that uses white noise to monitor infants' breathing

Researchers develop new smart speaker that uses white noise to monitor infants' breathing

Gone are the days when people use smart speakers - like Amazon Echo or Google Home - only as kitchen timers or dinner party music players. These devices have started helping people track their own health, and can even monitor for cardiac arrest.

16 Oct 2019

Non-invasive tape strips can be used in children to assess atopic dermatitis on the molecular level

Non-invasive tape strips can be used in children to assess atopic dermatitis on the molecular level

In a study using non-invasive tape strips in young children with eczema (or atopic dermatitis), researchers found many molecular signs of immune dysfunction and skin changes that relate to disease activity.

16 Oct 2019

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics, introduced the Cyto-Cellect Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

BioStreamline project outcomes

BioStreamline project outcomes

CPI have reported successful outcomes the £11.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Sphere Fluidics, announce it has opened a new office space at Granta Park. New facilities support the Company’s accelerated expansion.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

We are excited to release our latest software update with new Cyto-Mine functionalities!

We are excited to release our latest software update with new Cyto-Mine functionalities!

The Cyto-Mine Studio Suite contains a collection of software to allow Cyto-Mine operation and data acquisition.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

Sphere Fluidics, announced that it has closed an additional tranche of investment of $2.9 million, securing a total of $4.8 million in investment.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

Sphere Fluidics, announced today that it has appointed six new employees and plans to hire four more staff in its UK and US sites.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics, announced that is has closed a $2 million (circa £1.5 million) investment round.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

Sphere Fluidics, and Peak Analysis and Automation, will collaborate to offer automated micro-plate handling capabilities for single cell analysis.

From Fluidic Sciences and Sphere Bio 16 Oct 2019

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

We are delighted to announce that Cyto-Mine is one of the winners of The Scientist 2018 Top 10 Innovations!

From Fluidic Sciences and Sphere Bio 16 Oct 2019

Telescope technology used to take first undistorted images of eye area involved in glaucoma

Telescope technology used to take first undistorted images of eye area involved in glaucoma

Using methods originally developed by astronomers to view stars more clearly through Earth's atmosphere, optometry researchers at Indiana University have taken the first undistorted microscopic images of a part of the eye involved in glaucoma.

16 Oct 2019

NIH awards new contract to integrate pathogen and vector genomics database

NIH awards new contract to integrate pathogen and vector genomics database

A team led by scientists at the University of Pennsylvania and University of Georgia provides thousands of researchers around the world with access to the Eukaryotic Pathogen Genomics Database (EuPathDB.org), a collection of resources for analyzing large-scale datasets associated with microbial pathogens.

16 Oct 2019

CDISC and C-Path develop new standard to streamline data for animal rule studies

CDISC and C-Path develop new standard to streamline data for animal rule studies

The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Foundational Standard that describes how to represent data for the natural history and efficacy studies conducted in animals submitted to applications under the U.S. Food and Drug Administration (FDA) regulations commonly known as the Animal Rule.

16 Oct 2019

New initiative aims to use artificial intelligence to identify early drug candidates

New initiative aims to use artificial intelligence to identify early drug candidates

Insilico Medicine, in collaboration with ChemDiv, Inc., launched a drug discovery initiative that aims to use the power of artificial intelligence for screening chemistry space with newly designed compounds.

16 Oct 2019

White noise listening device for monitoring infant breathing

White noise listening device for monitoring infant breathing

Researchers at the University of Washington have come up with a device which acts as a monitor for infant breathing patterns while playing white noise to soothe them to sleep. The results of their study with the new device would be presented in an article titled, “Contactless Infant Monitoring using White Noise,” at the MobiCom 2019 conference in Los Cabos, Mexico on the 22nd of this month.

15 Oct 2019

Machine learning system may offer warnings about negative side effects of drug-drug interactions

Machine learning system may offer warnings about negative side effects of drug-drug interactions

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death.

15 Oct 2019

Amyloid-β protein misfolding proves to be strong risk prediction marker for Alzheimer's

Amyloid-β protein misfolding proves to be strong risk prediction marker for Alzheimer's

In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease - up to 14 years before a clinical diagnosis was made.

15 Oct 2019

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.